Table 2.
Neuroendocrine and immune status of control and previously abused women
| Controls | PTSD- | PTSD+ | |
|---|---|---|---|
| NE μg/day (n = 36)a | 32.4 (9.6) | 31.2 (14.6) | 36.7 (13.0) |
| Cortisol μg/day (n = 35)a | 82.2 (34.4) | 48.8 (17.1) | 22.2 (9.8) |
| CD4+ (n = 35) | 42.53 (13.13) | 44.95 (10.85) | 44.62 (11.09) |
| CD8+ (n = 35) | 24.17 (8.06) | 23.98 (6.68) | 22.99 (6.97) |
| CD4+CD45RA+ (early activation Th/I, n = 32)b | 17.7 (2.31) | 17.9 (2.21) | 23.97 (2.56) |
| CD8+CD45RA+ (early activation Tc/s, n = 32)b | 13.6 (1.32) | 13.6 (1.26) | 19.2 (1.45)* |
| CD45RO+ (memory T cells, n = 35)b | 40.2 (2.68) | 41.1 (2.47) | 32.7 (2.68)# |
a
Note: Data presented as total daily excretion not corrected by creatinine.
b
Data presented as percentage of lymphocyte subsets.
*
Post hoc Scheffe comparisons indicate significant differences between controls and PTSD+ as well as PTSD+ and PTSD- (p < .05), but not PTSD- and controls.
#
Overall effect of group comparison was marginal at F(2, 31) = 2.68, p = .085. Sample size differences reflect samples lost due to technical errors.